Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-06-01 to 2022-05-31
Current total value of award: $300000
Description: EO14042: THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A NOVEL HIV VACCINE CO-DELIVERY SYSTEM: AN INJECTABLE THERMOSENSITIVE HYDROGEL ENCAPSULATING POLYROTAXANE (PRX)-BASED SARNA (PRX-SARNA) NANOPARTICLES AND CYTOKINE ADJUVANT GM-CSF FOR TARGETED DELI